Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

To Live Better After Breast Cancer Treatment

NCT: NCT06471452 · ACTIVE_NOT_RECRUITING

NCT IDNCT06471452
StatusACTIVE_NOT_RECRUITING
Start Date2023-10-01
Completion2027-06
SponsorKarolinska Institutet (OTHER)
First posted
Last updated

Brief Summary

The most common cancer among women in Sweden is breast cancer. Advances in treatment have improved survival, but these advances have come at a steep price since most treatments impose substantial morbidity and burden on patients and their families. Furthermore, many survivors from cancer have ongoing poor health and well-being and long-term rehabilitation and support should not be neglected to prevent recurrence and increase survival. There are good reasons to believe that routine collection of relevant patient-reported symptoms facilitates person-centered care where the patient is a participatory member of the team. This study aims to pilot-test a supportive and person-centered care intervention in primary healthcare for six months during the first year after primary treatment for breast cancer, assisted by digital technology and compare it to standard care only. The intervention consists of symptom reporting and management in an app in combination with health dialogues with a study-specific nurse at the Primary healthcare centre.

Frequently Asked Questions

What is To Live Better After Breast Cancer Treatment?

To Live Better After Breast Cancer Treatment is a clinical trial registered under NCT06471452. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06471452?

The current status of NCT06471452 (To Live Better After Breast Cancer Treatment) is: ACTIVE_NOT_RECRUITING.

When did To Live Better After Breast Cancer Treatment start?

To Live Better After Breast Cancer Treatment started on 2023-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑